The AP2A1 Knockout HEK293T Polyclonal Cells product is a CRISPR/Cas9-edited polyclonal cell population in which the gene encoding ??-adaptin A (AP2A1), a core subunit of the adaptor protein complex AP-2, has been disrupted. This loss-of-function model is generated in the widely used HEK293T cell line and is provided as a polyclonal pool of edited cells, enabling researchers to investigate the functional consequences of AP2A1 deficiency on clathrin-mediated endocytosis and associated signaling pathways.
HEK293T cells are a human embryonic kidney epithelial line stably expressing the SV40 large T antigen. This expression allows for high-efficiency transient transfection and episomal replication of plasmids containing the SV40 origin of replication, making HEK293T an optimal host for protein expression studies, viral packaging, and a broad array of cell biology applications. The epithelial origin of these cells provides a physiologically relevant context for examining membrane trafficking events.
AP2A1 encodes the ??-adaptin A subunit of the heterotetrameric AP-2 complex, which includes ??2-adaptin (AP2B1), ??2-adaptin (AP2M1), and ??2-adaptin (AP2S1). This complex orchestrates clathrin-coated pit formation by binding clathrin and cargo with YXX?? motifs. AP2A1 activity is regulated by AAK1-mediated phosphorylation and PIP2 binding, promoting internalization of receptors such as EGFR, transferrin receptor, and GPCRs. Disruption of AP2A1 prevents AP-2 complex membrane recruitment, inhibiting clathrin-mediated endocytosis and impairing downstream signaling, including MAPK/ERK and Akt cascades downstream of EGFR, as well as Notch (NICD release) and Wnt/??-catenin (LRP6 internalization) pathways.
In the HEK293T background, AP2A1 knockout provides a clean system to dissect clathrin-mediated endocytosis in signal transduction and protein homeostasis. The cells’ high transfection efficiency permits expression of exogenous receptors or fusion proteins for trafficking studies on an AP2A1-deficient background. The polyclonal cell population minimizes clonal artifacts and enables robust, population-level functional analyses. This model is valuable for studying endocytic defects in cancer (e.g., dysregulated EGFR signaling) and neurodegenerative diseases like Alzheimer??s.
This AP2A1 knockout polyclonal model supports diverse endocytosis and receptor biology assays. Western blotting and immunofluorescence confirm AP2A1 loss and monitor clathrin/AP2B1. Transferrin uptake assays measure endocytosis activity; EGFR internalization is quantified by flow cytometry or confocal microscopy. Co-immunoprecipitation assesses AP-2 complex integrity. Transcriptional responses are evaluated by RT-qPCR or RNA-seq for endocytic pathway components. Applications include cancer biology, neurobiology, and drug delivery research. For additional information, please contact Ascent Research.
